Regentis Biomaterials Ltd. (RGNT) — Net Asset Quality Index
Regentis Biomaterials Ltd. (RGNT) has a Net Asset Quality Index of 62.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $7.62 Million minus total liabilities of $2.87 Million yields net assets of $4.74 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check RGNT cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Regentis Biomaterials Ltd. Net Asset Quality Index Over Time (2022–2025)
This chart shows how Regentis Biomaterials Ltd.'s Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 62.3%, representing net assets of $4.74 Million against total assets of $7.62 Million USD. See Regentis Biomaterials Ltd. (RGNT) shareholders funds for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Regentis Biomaterials Ltd. (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Regentis Biomaterials Ltd. from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Regentis Biomaterials Ltd. (RGNT) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.3% | $4.74 Million | $7.62 Million | $2.87 Million | ▲ +8590.1 pp |
| 2024 | -8527.8% | $-41.10 Million | $482.00K | $41.59 Million | ▲ +4223.6 pp |
| 2023 | -12751.4% | $-45.91 Million | $360.00K | $46.27 Million | ▼ -10301.7 pp |
| 2022 | -2449.7% | $-42.06 Million | $1.72 Million | $43.78 Million | — |